MicroDose Report issue

For profit Phase 1
Founded: Monmouth Junction NJ United States (1998)
Status: Acquired by Teva (2013)

Organization Overview

First Clinical Trial
2009
NCT00947596
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

MicroDose Defense Products L.L.C. | MicroDose Therapeutx, Inc

Active Ingredients

Drugs in Phase 1 Trials (2)

atropine (1 trial)

ttp889 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Organophosphate Poisoning (Phase 1)

Poisoning (Phase 1)

Respiratory Syncytial Virus Infections (Phase 1)

Virus Diseases (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 2